COVID‐19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report Redazione 28 Ottobre 2021 ...
Production and persistence of specific antibodies in COVID-19 patients with hematologic malignancies: role of rituximab Redazione 7 Ottobre 2021 ...
The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma Redazione 7 Ottobre 2021 ...
Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA): an open-label, randomised, phase 3 trial Redazione 23 Settembre 2021 ...
Acalabrutinib, venetoclax, and obinutuzumab as frontline treatment for chronic lymphocytic leukaemia: a single-arm, open-label, phase 2 study Redazione 23 Settembre 2021 ...
Heritable platelet disorders: an enigma even guidelines can’t unravel Redazione 23 Settembre 2021 ...
Correspondence in reference to the previously published Epub manuscript: immune thrombocytopenic purpura after SARS‐CoV‐2 vaccine Redazione 23 Settembre 2021 ...
Response to correspondence in reference to the previously published Epub manuscript: immune thrombocytopenic purpura after SARS‐CoV‐2 vaccine Redazione 23 Settembre 2021 ...
Safety and Antibody Response After 1 and 2 Doses of BNT162b2 mRNA Vaccine in Recipients of Allogeneic Hematopoietic Stem Cell Transplant Redazione 23 Settembre 2021 ...